| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 06/12/2002 | EP1212300A1 Azacycloalkanone serine protease inhibitors |
| 06/12/2002 | EP1212299A1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 06/12/2002 | EP1212298A1 Isolation of natural l-beta-3-indolylalanine and enrichment of natural aliphatic amino acid mixtures with natural l-beta-3-indolylalanine |
| 06/12/2002 | EP1212297A1 4-amino-1-aryl-1,5-dihydro-pyrrole-2-one with anti-convulsive and anxiolytic properties and a method for producing the same |
| 06/12/2002 | EP1212296A1 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 06/12/2002 | EP1212269A1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds |
| 06/12/2002 | EP1212120A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
| 06/12/2002 | EP1105386B1 Novel salt form of pantoprazole |
| 06/12/2002 | EP1023287B1 3-oxo-2(h)-1,2,4-triazine derivatives as ligands of 5ht1a receptors |
| 06/12/2002 | EP0934080B1 1,3-bis-(n-lactamyl) propane and the pharmaceutical and cosmetic use thereof |
| 06/12/2002 | EP0889879B1 Butadiene derivatives and process for preparing thereof |
| 06/12/2002 | EP0873320B1 Piperazine derivatives as tachykinin antagonists |
| 06/12/2002 | EP0776324B1 Endothelin antagonists |
| 06/12/2002 | EP0772603B1 Substituted pyrimidine compounds and their use |
| 06/12/2002 | EP0751939B1 Naphthylamides as central nervous system agents |
| 06/12/2002 | EP0688211B1 Thalidomide for inhibition of angiogenesis |
| 06/12/2002 | CN1353706A Integrin receptor ligands |
| 06/12/2002 | CN1353705A Pyrazinone thrombin inhibitors |
| 06/12/2002 | CN1353704A 取代吡唑化合物 A substituted pyrazole compound |
| 06/12/2002 | CN1353697A 4-phenyl-pyrimidine derivatives |
| 06/12/2002 | CN1353696A 5-phenyl-pyrimidine derivatives |
| 06/12/2002 | CN1353695A Heterocyclically substituted benzimidazoles, production and application thereof |
| 06/12/2002 | CN1353693A Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors |
| 06/12/2002 | CN1353691A Cell adhesion-inhibiting anti inflammatory and immune-suppresive compounds |
| 06/12/2002 | CN1353690A Bradykinin receptor antagonists |
| 06/11/2002 | US6403805 1,3-dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatves |
| 06/11/2002 | US6403794 Reacting a biguanidine with an alkoxycarbonyl, or a substituted triazine with ammonia or an alkylamine |
| 06/11/2002 | US6403792 Sulfonyl isatin compounds and methods of blocking apoptosis therewith |
| 06/11/2002 | US6403763 Chiral peptide nucleic acids which hybridize strongly with complementary nucleic acids; antigene and antisense agents; tools in molecular biology |
| 06/11/2002 | US6403680 Photo, heat, oxidation stabilizers |
| 06/11/2002 | US6403632 Cyclic amide derivative |
| 06/11/2002 | US6403628 Pesticidal 1-arylpyrazoles |
| 06/11/2002 | US6403620 Inhibitors of factor Xa with a neutral P1 specificity group |
| 06/11/2002 | US6403617 Including human cytomegalovirus, herpes simplex viruses, epstein-barr virus, varicella-zoster virus, humanherpesviruses-6 and -7, and kaposi herpesvirus |
| 06/11/2002 | US6403616 Chemical process and pharmaceutical formulation |
| 06/11/2002 | US6403613 Anti-inflammatory agent that reduces levels of cytokines (including tumor necrosis factor) |
| 06/11/2002 | US6403610 Quinolylpropylpiperidine derivatives, their preparation and the compositions which comprise them |
| 06/11/2002 | US6403608 3-Substituted isoquinolin-1-yl derivatives |
| 06/11/2002 | US6403607 Sulfonamide derivatives and drugs containing the same as the active ingredient |
| 06/11/2002 | US6403601 N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthalenecarboxamides and their use as neurokinin 1 (NK1) and/or neurokinin 2 (NK2) receptor antagonists |
| 06/11/2002 | US6403596 Substituted pyridones having cytokine inhibitory activity |
| 06/11/2002 | US6403595 Anticoagulants |
| 06/11/2002 | US6403587 Autoimmune diseases, acute and chronic inflammatory conditions, allergic conditions, infection associated with inflammation, viral, transplantation tissue rejection, atherosclerosis, restenosis, hiv infectivity, and |
| 06/11/2002 | US6403586 Interleukin inhibitors |
| 06/11/2002 | US6403584 Conjunctivitis, allergic rhinitis, alzheimer's disease, asthma, atherosclerosis, autologous bone marrow transplantation, antiinflammatory, etc |
| 06/11/2002 | US6403583 Anticoagulant agents for treatment and prevention of thromboembolic disorders. |
| 06/11/2002 | US6403582 Psychological disorders, antiinflammatory agents, gastrointestinal disorders |
| 06/11/2002 | US6403578 Anticoagulants, cardiovascular disorders |
| 06/11/2002 | US6403577 Hexamethyleneiminyl tachykinin receptor antagonists |
| 06/11/2002 | US6403575 3-Pyridyl enantiomers and their use as analgesics |
| 06/11/2002 | US6403573 Compounds of azetidine and pyrrolidin |
| 06/11/2002 | CA2239705C Quinazoline-4-one ampa antagonists |
| 06/06/2002 | WO2002044173A2 Herbicidal heterocycles |
| 06/06/2002 | WO2002044168A2 Indole-type inhibitors of p38 kinase |
| 06/06/2002 | WO2002044167A1 Process for the crystallization of (r)- or (s)-lansoprazole |
| 06/06/2002 | WO2002044166A1 Substituted quinolines as antitumor agents |
| 06/06/2002 | WO2002044165A1 Quinoline derivatives as nk-3 antagonists |
| 06/06/2002 | WO2002044164A1 0ovel farnesyl protein transferase inhibitors |
| 06/06/2002 | WO2002044156A2 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors |
| 06/06/2002 | WO2002044154A1 Novel compounds |
| 06/06/2002 | WO2002044153A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 06/06/2002 | WO2002044149A1 Indole and dihydroindole derivatives |
| 06/06/2002 | WO2002044145A1 New mandelic acid derivatives and their use as throbin inhibitors |
| 06/06/2002 | WO2002044141A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 06/06/2002 | WO2002044133A1 Preparation of sodium-hydrogen exchanger type-1 inhibitors |
| 06/06/2002 | WO2002043734A1 Novel compounds |
| 06/06/2002 | WO2002043733A1 Farnesyl protein transferase inhibitors for the treatment of inflammatory bowel disease |
| 06/06/2002 | WO2002024665A8 Arylalkane-sulfonamides having endothelin-antagonist activity |
| 06/06/2002 | WO2002020489A3 QUINOLINE INHIBITORS OF cGMP PHOSPHODIESTERASE |
| 06/06/2002 | WO2002020483A8 Piperidine derivatives for use 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 06/06/2002 | WO2002012198A3 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 06/06/2002 | WO2001090068A3 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases |
| 06/06/2002 | WO2001087849A3 Modulators of tnf- alpha signaling |
| 06/06/2002 | WO2001068614A3 5-substituted arylpyrimidines |
| 06/06/2002 | US20020068831 Intermediate for the synthesis of amlodipine, a process for the preparation there and corresponding use |
| 06/06/2002 | US20020068830 Such as 1-((1-(3-(cyclopentyloxy)-4-methoxyphenyl) cyclopropyl)methyl)-1,3-dihydro-2H-imidazol-2-one for allergies, atopic and inflammatory diseases wherein activity of phosphodiesterase is altered |
| 06/06/2002 | US20020068827 Quinoline-4-carboxamide derivatives, their preparation and their use as neurokinin 3 ( NK-3 ) - and neurokinin 2 ( NK-3 ) receptor antagonists |
| 06/06/2002 | US20020068756 Inhibition of phosphodiesterase; 3-carbocyclic(alkyl)oxy-2-aryl(alkyl)aminocarbonyl-1-aryl(alkyl)indole or azaindole derivatives |
| 06/06/2002 | US20020068755 Antitumor agents. |
| 06/06/2002 | US20020068753 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 06/06/2002 | US20020068742 Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 06/06/2002 | US20020068734 Nitrogen-containing heterocyclic compounds |
| 06/06/2002 | US20020068733 Especially for controlling insects. |
| 06/06/2002 | US20020068730 New amidino derivatives and their use as thormbin inhibitors |
| 06/06/2002 | DE10060412A1 DELTA1-Pyrroline DELTA1-pyrrolines |
| 06/06/2002 | CA2430354A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 06/06/2002 | CA2430061A1 Preparation of sodium-hydrogen exchanger type-1 inhibitors |
| 06/06/2002 | CA2429382A1 Indole-type inhibitors of p38 kinase |
| 06/06/2002 | CA2422729A1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 06/05/2002 | EP1211249A1 Novel thiazine or pyrazine derivatives |
| 06/05/2002 | EP1211247A1 Acylamino cyclopropane derivatives |
| 06/05/2002 | EP1211246A1 Pyrimidine derivatives and herbicides containing the same |
| 06/05/2002 | EP1211244A2 4,5-substitued imidazolyl compounds for the treatment of inflammation |
| 06/05/2002 | EP1210941A2 Pharmaceutical compositions containing ritonavir (ABT-538) in combination with indinavir (MK-639) and their use for treating AIDS |
| 06/05/2002 | EP1210598A1 4-unsubstituted dihydroisoquinolinone derivatives and combinatorial libraries thereof |
| 06/05/2002 | EP1210344A1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 06/05/2002 | EP1210343A2 Benzoic acid derivatives and their use as ppar receptor agonists |
| 06/05/2002 | EP1210339A1 Benzoic acid derivatives for the treatment of diabetes mellitus |
| 06/05/2002 | EP1210336A1 Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase |
| 06/05/2002 | EP1210335A1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments |